1. A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation. Issue 10 (9th October 2020) Authors: Kerr, Sheena C; Morgan, Molly M; Gillette, Amani A; Livingston, Megan K; Lugo-Cintron, Karina M; Favreau, Peter F; Florek, Logan; Johnson, Brian P; Lang, Joshua M; Skala, Melissa C; Beebe, David J Journal: Integrative biology Issue: Volume 12:Issue 10(2020) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer. Issue 9 (11th August 2021) Authors: Daniel, Mark; Knutson, Todd P; Sperger, Jamie M; Li, Yingming; Singh, Anupama; Stahlfeld, Charlotte N; Passow, Courtney; Auch, Benjamin; Lang, Joshua M; Dehm, Scott M Journal: Endocrine-related cancer Issue: Volume 28:Issue 9(2021) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular analysis of antigen presentation machinery in circulating tumor cells from renal cell carcinoma and prostate cancer. (7th November 2013) Authors: Lang, Joshua M; Tokar, Jacob T; Sperger, Jamie; Casavant, Benjamin P; Berry, Scott M; Strotman, Lindsay N; Beebe, David J Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). Issue 3 (11th March 2022) Authors: McNeel, Douglas G; Eickhoff, Jens C; Wargowski, Ellen; Johnson, Laura E; Kyriakopoulos, Christos E; Emamekhoo, Hamid; Lang, Joshua M; Brennan, Mary Jane; Liu, Glenn Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies. (November 0201) Authors: Kosoff, David; Krueger, Timothy; Lang, Joshua M Journal: Immunotherapy Issue: Volume 5:Number 11(2013:Nov.) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗